Robbie Marcus
Stock Analyst at JP Morgan
(3.88)
# 663
Out of 5,090 analysts
175
Total ratings
54.78%
Success rate
8.45%
Average return
Main Sectors:
Stocks Rated by Robbie Marcus
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| COO The Cooper Companies | Maintains: Neutral | $66 → $78 | $81.40 | -4.18% | 7 | Dec 5, 2025 | |
| MDT Medtronic | Maintains: Neutral | $90 → $100 | $101.36 | -1.34% | 12 | Nov 13, 2025 | |
| HTFL HeartFlow | Maintains: Overweight | $36 → $40 | $27.53 | +45.30% | 2 | Nov 13, 2025 | |
| CNMD CONMED | Maintains: Neutral | $58 → $52 | $40.07 | +29.77% | 8 | Nov 6, 2025 | |
| RXST RxSight | Maintains: Underweight | $8 → $9 | $12.63 | -28.74% | 6 | Nov 6, 2025 | |
| ZBH Zimmer Biomet Holdings | Downgrades: Neutral | $115 → $100 | $94.28 | +6.07% | 7 | Nov 6, 2025 | |
| CBLL CeriBell | Maintains: Overweight | $21 → $17 | $19.72 | -13.79% | 2 | Nov 5, 2025 | |
| INSP Inspire Medical Systems | Maintains: Neutral | $110 → $82 | $136.81 | -40.06% | 7 | Nov 4, 2025 | |
| DXCM DexCom | Maintains: Neutral | $90 → $75 | $65.49 | +14.52% | 3 | Oct 31, 2025 | |
| IART Integra LifeSciences Holdings | Maintains: Underweight | $12 → $13 | $13.23 | -1.74% | 7 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $85 → $90 | $86.19 | +4.42% | 6 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $13 → $16 | $16.82 | -4.88% | 3 | Oct 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $14 → $16 | $16.40 | -2.44% | 5 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $15 → $7 | $9.05 | -22.65% | 7 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $120 | $83.43 | +43.83% | 1 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $38 → $36 | $18.54 | +94.17% | 17 | Feb 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $420 → $445 | $364.02 | +22.25% | 9 | Jan 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $575 → $675 | $575.34 | +17.32% | 5 | Jan 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $12 → $13 | $7.09 | +83.36% | 3 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $100 → $110 | $97.52 | +12.80% | 13 | Dec 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $280 → $330 | $304.49 | +8.38% | 4 | Dec 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $30 → $40 | $39.86 | +0.35% | 5 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $90 | $85.46 | +5.31% | 1 | Sep 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $53 → $50 | $27.02 | +85.05% | 2 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $15 → $8 | $2.74 | +191.97% | 2 | May 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $284 → $250 | $300.66 | -16.85% | 9 | Feb 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $8 → $7 | $6.94 | +0.86% | 13 | Nov 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $125 → $118 | $125.08 | -5.66% | 5 | Oct 20, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $116 → $156 | $178.37 | -12.54% | 2 | Jan 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $55 → $40 | $108.51 | -63.14% | 2 | May 5, 2020 |
The Cooper Companies
Dec 5, 2025
Maintains: Neutral
Price Target: $66 → $78
Current: $81.40
Upside: -4.18%
Medtronic
Nov 13, 2025
Maintains: Neutral
Price Target: $90 → $100
Current: $101.36
Upside: -1.34%
HeartFlow
Nov 13, 2025
Maintains: Overweight
Price Target: $36 → $40
Current: $27.53
Upside: +45.30%
CONMED
Nov 6, 2025
Maintains: Neutral
Price Target: $58 → $52
Current: $40.07
Upside: +29.77%
RxSight
Nov 6, 2025
Maintains: Underweight
Price Target: $8 → $9
Current: $12.63
Upside: -28.74%
Zimmer Biomet Holdings
Nov 6, 2025
Downgrades: Neutral
Price Target: $115 → $100
Current: $94.28
Upside: +6.07%
CeriBell
Nov 5, 2025
Maintains: Overweight
Price Target: $21 → $17
Current: $19.72
Upside: -13.79%
Inspire Medical Systems
Nov 4, 2025
Maintains: Neutral
Price Target: $110 → $82
Current: $136.81
Upside: -40.06%
DexCom
Oct 31, 2025
Maintains: Neutral
Price Target: $90 → $75
Current: $65.49
Upside: +14.52%
Integra LifeSciences Holdings
Oct 31, 2025
Maintains: Underweight
Price Target: $12 → $13
Current: $13.23
Upside: -1.74%
Oct 31, 2025
Maintains: Neutral
Price Target: $85 → $90
Current: $86.19
Upside: +4.42%
Oct 30, 2025
Maintains: Neutral
Price Target: $13 → $16
Current: $16.82
Upside: -4.88%
May 14, 2025
Maintains: Overweight
Price Target: $14 → $16
Current: $16.40
Upside: -2.44%
May 9, 2025
Downgrades: Underweight
Price Target: $15 → $7
Current: $9.05
Upside: -22.65%
Mar 28, 2025
Initiates: Overweight
Price Target: $120
Current: $83.43
Upside: +43.83%
Feb 21, 2025
Maintains: Neutral
Price Target: $38 → $36
Current: $18.54
Upside: +94.17%
Jan 29, 2025
Maintains: Overweight
Price Target: $420 → $445
Current: $364.02
Upside: +22.25%
Jan 24, 2025
Maintains: Overweight
Price Target: $575 → $675
Current: $575.34
Upside: +17.32%
Dec 17, 2024
Upgrades: Neutral
Price Target: $12 → $13
Current: $7.09
Upside: +83.36%
Dec 16, 2024
Maintains: Overweight
Price Target: $100 → $110
Current: $97.52
Upside: +12.80%
Dec 12, 2024
Maintains: Overweight
Price Target: $280 → $330
Current: $304.49
Upside: +8.38%
Oct 30, 2024
Maintains: Overweight
Price Target: $30 → $40
Current: $39.86
Upside: +0.35%
Sep 9, 2024
Initiates: Neutral
Price Target: $90
Current: $85.46
Upside: +5.31%
Aug 8, 2024
Maintains: Neutral
Price Target: $53 → $50
Current: $27.02
Upside: +85.05%
May 8, 2024
Downgrades: Neutral
Price Target: $15 → $8
Current: $2.74
Upside: +191.97%
Feb 23, 2024
Downgrades: Neutral
Price Target: $284 → $250
Current: $300.66
Upside: -16.85%
Nov 8, 2023
Maintains: Underweight
Price Target: $8 → $7
Current: $6.94
Upside: +0.86%
Oct 20, 2022
Maintains: Overweight
Price Target: $125 → $118
Current: $125.08
Upside: -5.66%
Jan 27, 2022
Maintains: Overweight
Price Target: $116 → $156
Current: $178.37
Upside: -12.54%
May 5, 2020
Maintains: Neutral
Price Target: $55 → $40
Current: $108.51
Upside: -63.14%